Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.65
(-7.14%)
CAD 0.65
(-7.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -506.04 Thousand CAD | -293.01% |
| 2022 | -128.76 Thousand CAD | 78.21% |
| 2021 | -590.89 Thousand CAD | 29.54% |
| 2020 | -838.65 Thousand CAD | -48.75% |
| 2019 | -563.79 Thousand CAD | 0.38% |
| 2018 | -565.92 Thousand CAD | 3.8% |
| 2017 | -588.27 Thousand CAD | -15.92% |
| 2016 | -507.49 Thousand CAD | -75.98% |
| 2015 | -288.38 Thousand CAD | 43.02% |
| 2014 | -506.07 Thousand CAD | -252.36% |
| 2013 | -143.62 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -64.74 Thousand CAD | 57.39% |
| 2024 Q2 | -133.26 Thousand CAD | -105.84% |
| 2024 Q3 | -90.55 Thousand CAD | 24.01% |
| 2023 Q3 | -115.06 Thousand CAD | 33.2% |
| 2023 FY | -506.04 Thousand CAD | -293.01% |
| 2023 Q1 | -66.06 Thousand CAD | -68.23% |
| 2023 Q2 | -172.25 Thousand CAD | -160.75% |
| 2023 Q4 | -151.94 Thousand CAD | -32.05% |
| 2022 Q3 | -9501.00 CAD | 88.16% |
| 2022 FY | -128.76 Thousand CAD | 78.21% |
| 2022 Q4 | -39.27 Thousand CAD | -313.32% |
| 2022 Q2 | -80.21 Thousand CAD | -611.41% |
| 2022 Q1 | -11.27 Thousand CAD | -83.01% |
| 2021 FY | -590.89 Thousand CAD | 29.54% |
| 2021 Q3 | -175.22 Thousand CAD | 23.15% |
| 2021 Q4 | -6161.00 CAD | 96.48% |
| 2021 Q2 | -228.02 Thousand CAD | -18.27% |
| 2021 Q1 | -192.79 Thousand CAD | 29.15% |
| 2020 Q4 | -272.12 Thousand CAD | -395.83% |
| 2020 Q1 | -244.7 Thousand CAD | -32.9% |
| 2020 Q2 | -273.52 Thousand CAD | -11.78% |
| 2020 Q3 | -54.88 Thousand CAD | 79.94% |
| 2020 FY | -838.65 Thousand CAD | -48.75% |
| 2019 Q1 | -7373.00 CAD | -154.58% |
| 2019 Q2 | -294.75 Thousand CAD | -3897.75% |
| 2019 Q3 | -94.25 Thousand CAD | 68.02% |
| 2019 Q4 | -184.13 Thousand CAD | -95.35% |
| 2019 FY | -563.79 Thousand CAD | 0.38% |
| 2018 Q2 | -235.52 Thousand CAD | -33.83% |
| 2018 FY | -565.92 Thousand CAD | 3.8% |
| 2018 Q4 | 13.5 Thousand CAD | 108.04% |
| 2018 Q3 | -167.92 Thousand CAD | 28.7% |
| 2018 Q1 | -175.99 Thousand CAD | -5.25% |
| 2017 Q1 | -141.37 Thousand CAD | -2.72% |
| 2017 Q2 | -129.59 Thousand CAD | 8.33% |
| 2017 Q4 | -167.21 Thousand CAD | -12.97% |
| 2017 FY | -588.27 Thousand CAD | -15.92% |
| 2017 Q3 | -148.02 Thousand CAD | -14.22% |
| 2016 Q1 | -94.01 Thousand CAD | -88.8% |
| 2016 Q2 | -124.65 Thousand CAD | -32.59% |
| 2016 Q3 | -151.2 Thousand CAD | -21.3% |
| 2016 FY | -507.49 Thousand CAD | -75.98% |
| 2016 Q4 | -137.62 Thousand CAD | 8.98% |
| 2015 Q1 | -173.76 Thousand CAD | 34.41% |
| 2015 Q3 | -42.36 Thousand CAD | -256.73% |
| 2015 Q4 | -49.79 Thousand CAD | -17.54% |
| 2015 Q2 | -11.87 Thousand CAD | 93.17% |
| 2015 FY | -288.38 Thousand CAD | 43.02% |
| 2014 Q1 | -40.59 Thousand CAD | 57.97% |
| 2014 Q2 | -89.39 Thousand CAD | -120.21% |
| 2014 Q3 | -112.26 Thousand CAD | -25.59% |
| 2014 Q4 | -264.94 Thousand CAD | -136.01% |
| 2014 FY | -506.07 Thousand CAD | -252.36% |
| 2013 FY | -143.62 Thousand CAD | 0.0% |
| 2013 Q4 | -96.58 Thousand CAD | -85.69% |
| 2013 Q3 | -52.01 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|